IHH Healthcare Bhd has announced an undisclosed investment in Belun Technology Company Limited, a pioneer in sleep disorder detection and diagnosis. Belun’s breakthrough lies in its FDA-cleared, artificial intelligence-powered at-home wearable sleep test ring and software, the first of its kind.
IHH Healthcare Group CEO Dr Prem Nair noted the significance of this investment in enhancing patient care through innovative technologies.
“Our investment in Belun underscores our commitment to enhance care and services to our patients through the strategic adoption of AI and other innovative technologies. By partnering with promising ventures, we are expanding our capabilities and creating value across the healthcare continuum.
“As the global prevalence of sleep disorders rises alongside related health challenges, IHH as a leading healthcare provider is taking steps to make sleep health services more convenient and accessible, extending holistic care beyond our hospital walls,” he stated.
Moreover, IHH Healthcare is exploring further collaboration with Belun to tackle other health conditions associated with sleep disorders. Sleep problems affect a considerable portion of the global population, yet many cases remain untreated due to lack of awareness or access to professional help.
Belun Technology specialises in AI-powered sleep diagnostic and screening solutions, offering comprehensive management of sleep apnea and other disorders. Its wearable ring and software have undergone clinical validation in accredited sleep labs, providing physicians and sleep specialists with valuable insights into patients’ sleep stages for personalised treatment planning. – May 8, 2024
